Discover 3,005 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,005
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Location: Orange CA, San Diego CA, Houston TX, Rochester MN,
Sponsor: Medigus Ltd
Sex: All
Age: 18 - 70
Code: NCT02366169
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
for
Bladder Carcinoma, Genitourinary System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05519878
Recruiting
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: Newport Beach CA, El Segundo CA
Sponsor: ImmunityBio, Inc.
Sex: Female
Age: 18 - 70+
Code: NCT06710288
Phase 2, Recruiting
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
for
B-cell Malignancy, Chronic Lymphocytic Leukemia,
Location: Orange CA, Houston TX, Milwaukee WI, Chicago IL,
Sponsor: Carna Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05602363
Phase 1, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: Orange CA, Stanford CA, Sacramento CA, Aurora CO,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05384626
Phase 1, Phase 2, Recruiting
Effect of Electro-Acupuncture on Blood Pressure
for
Hypertension
Location: Orange CA, Irvine CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70+
Code: NCT00932139
Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Orange CA, Los Angeles CA, Gilbert AZ, San Francisco CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase 1, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Burbank CA, Phoenix AZ, Reno NV, Grand Junction CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06170788
Phase 3, Recruiting
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
for
T-Cell Neoplasm, Lymphoproliferative Disorders
Location: Duarte CA, Ann Arbor MI, Columbus OH, Durham NC
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT04858256
Phase 2, Recruiting
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
for
Hypogammaglobulinemia, Bacterial Infections,
Location: Huntington Park CA, Bullhead City AZ, Canton OH,
Sponsor: Grifols Therapeutics LLC
Sex: All
Age: 18+
Code: NCT05645107
Phase 3, Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Location: Irvine CA, Los Angeles CA, San Diego CA,
Sponsor: Lyell Immunopharma, Inc.
Sex: All
Age: 18+
Code: NCT05826535
Phase 1, Phase 2, Recruiting
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, Dallas TX, Houston TX, Ann Arbor MI,
Sponsor: LigaChem Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05941507
Phase 1, Phase 2, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Burbank CA, La Jolla CA, Palo Alto CA,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
for
Necrotizing Soft Tissue Infection
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT06002607
Recruiting
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
for
Breast Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT06171607
Phase 1, Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
for
Down Syndrome, Alzheimer Disease, Dementia
Location: Orange CA, Phoenix AZ, Aurora CO, San Antonio TX,